| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 152.29M | 169.88M | 197.89M | 243.34M | 245.57M | 175.08M |
| Gross Profit | 53.29M | 146.58M | 186.06M | 229.77M | 231.32M | 154.88M |
| EBITDA | 27.89M | 31.56M | 13.56M | 92.35M | 91.55M | 42.49M |
| Net Income | 12.66M | 16.70M | -3.49M | 39.33M | 59.20M | 27.67M |
Balance Sheet | ||||||
| Total Assets | 269.84M | 354.48M | 426.36M | 505.23M | 466.92M | 481.54M |
| Cash, Cash Equivalents and Short-Term Investments | 48.36M | 79.77M | 112.47M | 130.96M | 125.02M | 74.09M |
| Total Debt | 845.00K | 1.51M | 2.54M | 2.17M | 3.67M | 5.02M |
| Total Liabilities | 157.94M | 216.32M | 255.13M | 284.25M | 282.75M | 318.15M |
| Stockholders Equity | 111.89M | 138.16M | 171.23M | 220.98M | 184.17M | 163.39M |
Cash Flow | ||||||
| Free Cash Flow | 5.94M | 20.04M | 28.06M | 43.16M | 11.61M | 43.39M |
| Operating Cash Flow | 6.47M | 20.63M | 28.21M | 43.42M | 12.12M | 43.64M |
| Investing Cash Flow | 2.88M | 3.32M | 2.76M | 11.27M | -2.54M | -53.16M |
| Financing Cash Flow | -51.59M | -52.37M | -47.68M | -54.50M | -42.10M | 41.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £8.97B | 11.95 | 12.35% | 5.37% | 4.78% | -4.86% | |
74 Outperform | £803.33M | 8.25 | 11.49% | 2.70% | -4.38% | ― | |
70 Outperform | £2.13B | 17.89 | 4.75% | 4.91% | 14.05% | -3.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | £149.44M | 11.47 | 9.72% | 21.31% | -15.65% | -12.27% | |
52 Neutral | £68.90M | 80.13 | 1.07% | 11.43% | -3.99% | -36.07% | |
52 Neutral | £6.93B | 22.80 | 9.49% | 7.09% | 9.86% | -134.41% |